ALTA-Sodium Phosphate
Natural health product licensed in Canada
- Licence holder
- Altamed Pharma
- NPN or DIN-HM
- 80089404
- Status
- Active licence
- Licence date
- 3 December 2018
- Revision date
- 25 January 2019
- Form
- Comprimé, effervescent
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phosphore Source : Phosphate de sodium dibasique | 500 mg | Not calculated |
| Potassium Source : Bicarbonate de potassium | 123 mg | Not calculated |
| Sodium Source : Bicarbonate de sodium | 1,214 mg | Not calculated |
| Sodium Source : Sodium benzoate | 1,214 mg | Not calculated |
| Sodium Source : Phosphate de sodium dibasique | 1,214 mg | Not calculated |
Non-medicinal ingredients
Benzoate de sodium, Sucralose, Saveur d'orange, Poly(éthylène glycol), Maltodextrine, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Hypercalciuria, electrolyte replenisher.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use if you have - a cardiac disease treated with digitalis, adrenal insufficiency, acute dehydration, severe renal insufficiency, cardiac failure, liver cirrhosis or severe hepatic disease, gastrointestinal lesion/ulcer/disorder, osteoporosis, edema, hypernatremia, hypertension or toxaemia or pregnancy. - If you are following a high-protein diet, taking high-dose vitamin C or prescription medications
- Effets indésirables connus
The following reactions have been reported: Nausea, vomiting, stomach pain, laxative effect or diarrhea, and less frequently: Fluid retention associated with swelling of feet and/or weight gain, hyperkalemia associated with confusion, tiredness or weakness; irregular or slow heart beat; numbness or tingling around lips, hands or feet; unexplained anxiety; breathing problems, hypernatremia associated with confusion; tiredness or weakness; convulsions; decrease in urine volume or in frequency of urine; fast heartbeat; headache or dizziness; increased thirst; hyperphosphatemia or hypocalcemic tetany associated with muscle cramps; numbness, tingling, pain, or weakness in hands or feet, shortness of breath or troubled breathing.
- Contre-indications
Do not use - If hyperphosphatemia is present or in the presence of severe impairment or renal function (less than 30% of normal). - If you have distal renal tubular acidosis, or calculi secondary to infection - With other potassium-containing supplements or with potassium-containing salt-substitutes
Source
Official Health Canada record, licence 80089404
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging